A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)

Condition:   AsthmaInterventions:   Drug: MK0476; montelukast sodium/Duration of Treatment: 16 weeks;   Drug: Comparator: placebo / Duration of Treatment: 16 weeksSponsor:   Merck Sharp & Dohme Corp.Completed - verified October 2014

Source: ClinicalTrials.gov - August 31, 2005 Category: Research Source Type: clinical trials